1-4 of 4
M.R. Baer
Close
Sort by
Journal Articles

Deferasirox (ICL670; Exjade®) Reduces Serum Ferritin (SF) and Labile Plasma Iron (LPI) in Patients with Myelodysplastic Syndromes (MDS).

Alan F. List, M.R. Baer, D. Steensma, A. Raza, J. Esposito, J. Virkus, J. Feigert, E. Besa, C. Paley
Journal: Blood
Blood (2007) 110 (11): 1470.
https://doi.org/10.1182/blood.V110.11.1470.1470
Published: 2007
Journal Articles

Long-Term Follow-Up of Multiple Myeloma (MM) Patients (pts) with Osteonecrosis of the Jaw (ONJ).

Ashraf Badros, T. Evangelos, O. Goloubeva, T. Meiller, E. Kastritis, E. Verrou, K. Zervas, E. Katodritou, E. Streeten, M.R. Baer, M.A. Dimopoulos
Journal: Blood
Blood (2007) 110 (11): 3519.
https://doi.org/10.1182/blood.V110.11.3519.3519
Published: 2007
Journal Articles

Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).

Ashraf Badros, S. Philip, R. Niesvizky, O. Goloubeva, C. Harris, J. Zweibel, J. Wright, A. Burger, S. Grant, M.R. Baer, M.J. Egorin
Journal: Blood
Blood (2007) 110 (11): 1168.
https://doi.org/10.1182/blood.V110.11.1168.1168
Published: 2007
Journal Articles

Overexpression of the ERG Gene Is an Adverse Prognostic Factor in Acute Myeloid Leukemia (AML) with Normal Cytogenetics (NC): A Cancer and Leukemia Group B Study (CALGB).

Guido Marcucci, C.D. Baldus, A.S. Ruppert, M.D. Radmacher, K. Mrózek, S.P. Whitman, J.E. Kolitz, C.G. Edwards, J.W. Vardiman, B.L. Powell, M.R. Baer, J.O. Moore, D. Perrotti, M.A. Caligiuri, A.J. Carroll, R.A. Larson, A. de la Chapelle, C.D. Bloomfield
Journal: Blood
Blood (2005) 106 (11): 335.
https://doi.org/10.1182/blood.V106.11.335.335
Published: 2005